Who Paid My Doc
Michael Mont
Adult Reconstructive Orthopaedic Surgery Baltimore, MD Medical Doctor
NPI 1679516751 CMS profile 496476
2401 W Belvedere Ave Fl 5, Baltimore, MD 21215
General payments
$10,944,585
Research payments
$19,219
Ownership & investment interest
$0
Research they led as principal investigator
$357,175
Through program year 2025, Michael Mont of Baltimore, MD is reported in the CMS Open Payments database as having received $10,944,585 across 549 general payments and $19,219 in research payments paid to them. Separately, studies naming them as principal investigator received $357,175 in research payments, paid to institutions rather than to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.
General payments for this record sit in the 99th percentile of Adult Reconstructive Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
11 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $1,762,551 | 80 | |
| 2025 | Research | $2,279 | 8 | |
| 2024 | General | $2,011,554 | 124 | |
| 2023 | General | $1,546,344 | 86 | |
| 2022 | General | $1,424,901 | 74 | |
| 2021 | General | $1,576,009 | 59 | |
| 2021 | Research | $2,180 | 2 | |
| 2020 | General | $1,239,125 | 42 | |
| 2020 | Research | $4,760 | 3 | |
| 2019 | General | $1,384,100 | 84 | |
| 2019 | Research | $10,000 | 1 |
Beside peers
- Michael Mont
- Adult Reconstructive Orthopaedic Surgery median
- Middle half of Adult Reconstructive Orthopaedic Surgery
- National median
In program year 2025, general payments to Michael Mont were reported at $1,762,551. Among 1,079 Adult Reconstructive Orthopaedic Surgery profiles paid that year, the median was $1,406 and the middle half received between $318 and $8,709.
Show as a table
| Year | Michael Mont | Adult Reconstructive Orthopaedic Surgery median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $1,384,100 | $1,416 | $292–$9,336 | $163 |
| 2020 | $1,239,125 | $647 | $141–$6,474 | $114 |
| 2021 | $1,576,009 | $1,073 | $211–$6,497 | $132 |
| 2022 | $1,424,901 | $1,217 | $236–$6,299 | $149 |
| 2023 | $1,546,344 | $1,082 | $246–$6,818 | $160 |
| 2024 | $2,011,554 | $1,575 | $323–$8,944 | $164 |
| 2025 | $1,762,551 | $1,406 | $318–$8,709 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Billing to Medicare
Part B · data year 2024 · 57 billing codesPaid by Medicare
$109,486
Medicare patients
220
Services billed
969
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| High blood pressure | 75% | |
| Arthritis | 75% | |
| Depression | 39% | |
| Diabetes | 36% | |
| Ischemic heart disease | 30% | |
| Chronic kidney disease | 26% | |
| COPD | 16% | |
| Cancer | 16% |
| Drug given in the clinic | Where | Patients | Services | Paid by Medicare |
|---|---|---|---|---|
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg J3301 | Office | 30 | 240 | $180 |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Payments and prescribing
1 product · payments 2024Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.
| Product | Paid by | Related payments | Part D claims | Part B services |
|---|---|---|---|---|
| Zilretta |
|
$120,000 | — | — |
A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.
Records
563 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Adult Reconstructive Orthopaedic Surgery in Maryland
Randal Lewis
Adult Reconstructive Orthopaedic Surgery · Chevy Chase, MD
Sridhar Durbhakula
Adult Reconstructive Orthopaedic Surgery · Bethesda, MD
Pasquale Petrera
Adult Reconstructive Orthopaedic Surgery · Salisbury, MD
Pablo Wagner
Adult Reconstructive Orthopaedic Surgery · Baltimore, MD
James Nace
Adult Reconstructive Orthopaedic Surgery · Baltimore, MD
John Steele
Adult Reconstructive Orthopaedic Surgery · Towson, MD
Related records
Adult Reconstructive Orthopaedic Surgery in Maryland
Practitioners in the same specialty and state, ranked by reported value.
All Adult Reconstructive Orthopaedic Surgery
Everyone recorded under this specialty, nationwide.
Doctors in Maryland
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.